Author: Matthew Perrone, Associated Press

Supreme Court Upholds Access to Abortion Pill Mifepristone In a significant victory for abortion rights, the U.S. Supreme Court unanimously rejected efforts to restrict access to the abortion pill mifepristone, maintaining its availability for women in states where abortion is legal. While this ruling preserves the status quo, it highlights the ongoing challenges faced by women seeking reproductive healthcare. Key Points of the Decision: The Supreme Court’s decision reaffirms the FDA’s approval of mifepristone and its safety for ending pregnancies. Despite this victory, women’s access to the pill varies across states due to different laws and restrictions. Understanding Mifepristone: Mifepristone…

In a groundbreaking development, federal health regulators are exploring the potential use of MDMA, commonly known as ecstasy or molly, as a treatment for PTSD. The FDA’s initial review highlighted the positive impact of MDMA combined with talk therapy on patients suffering from PTSD symptoms. Despite acknowledging the promising results, FDA scientists raised concerns about the safety and long-term effectiveness of the treatment. The upcoming meeting of outside advisors will play a crucial role in determining the drug’s overall benefits and risks before the FDA makes the final decision in August. If approved, MDMA would become a prescription medication available…